You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 21, June 7, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Brain Cancer
 •Oncology, Other
 •Surgery
 •Surgical Interventions
 •Surgical Oncology
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Radiosurgery and Whole-Brain Radiation Therapy for Brain Metastases

Either or Both as the Optimal Treatment

Jeffrey Raizer, MD

JAMA. 2006;295:2535-2536.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Brain metastases are the most feared and debilitating complication of systemic cancers. They affect approximately 170 000 patients a year, with the most common primary tumors being lung cancer, breast cancer, and melanoma.1 The traditional approach for patients with brain metastases has been whole-brain radiation therapy (WBRT), irrespective of lesion number or primary site.

A shift in treatment occurred for patients with a single brain metastasis after 3 randomized trials were completed.2-4 In these trials patients were randomized to receive WBRT alone or surgical resection of a single brain metastasis followed by WBRT. In studies by Patchell et al2 and Noordijk et al,3 resection of a single brain metastasis prior to WBRT led to an increase in median survival of 25 and 17 weeks, respectively. There was also a significant increase in functionality for the surgical group in both studies. A study by Mintz et al4 did not . . . [Full Text of this Article]

Author Affiliation: Feinberg School of Medicine, Northwestern University, Chicago, Ill.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Radiosurgery plus whole-brain radiation therapy for brain metastases.
, , , , , and
JAMA. ;296():2089-2090.
FULL TEXT  

Radiosurgery Plus Whole-Brain Radiation Therapy for Brain Metastases--Reply
, , , , and
JAMA. ;296():2090-2090.
FULL TEXT  

Radiosurgery Plus Whole-Brain Radiation Therapy for Brain Metastases--Reply

JAMA. ;296():2090-2091.
FULL TEXT  

RELATED ARTICLE

Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.
, , , , , , , , , , , , , , and
JAMA. ;295():2483-2491.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Questionnaire Survey of Treatment Choice for Breast Cancer Patients with Brain Metastasis in Japan: Results of a Nationwide Survey by the Task Force of the Japanese Breast Cancer Society
Matsumoto et al.
Jpn J Clin Oncol 2009;39:22-26.
ABSTRACT | FULL TEXT  

Radiosurgery plus whole-brain radiation therapy for brain metastases.
Patchell et al.
JAMA 2006;296:2089-2090.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.